Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced that it has received 510(k) clearances from the Food and Drug Administration (FDA) for its TAPESTRY RC System for the treatment of rotator cuff disease. Uniquely designed for arthroscopic procedures, TAPESTRY RC System combines the healing benefits of the biointegrative collagen TAPESTRY …

CARLSBAD, Calif., /PRNewswire/ — GPB Scientific, Inc. has launched its go-to-market activities for the transformational Curate® Cell Processing System to streamline the manufacture of cell therapies, making them economically and reliably available to the largest number of patients. The company’s advanced cell separation platform is in evaluations at select biopharmas, contract manufacturers, and academic centers …

Civica, Inc. announced that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of Directors …

Civica Chief Operating Officer Ned McCoy to Serve as Civica’s Next President and Chief Executive Officer. Martin VanTrieste to Retire as CEO; Will Continue Serving on Civica Board of Directors. LEHI, Utah–(BUSINESS WIRE)–Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and …

Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in pediatric technologies that aim to address unmet medical needs for children, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will …

Roanoke, Va. — The biggest night in  tech celebrated the rapidly  expanding technology ecosystem and the movers and shakers in the industry on  Thursday night at Roanoke-Blacksburg Technology Council’s TechNite 2022 at the  Taubman Museum of Art, attracting over 300 statewide and regional leaders.  Among the highlights of the evening was the induction of Victor …

There is no doubt that Virginia is open for business to the life sciences industry. Over the past several years, the state has seen significant growth in pocket ecosystems across the land, particularly in areas like Charlottesville, Richmond, and Blacksburg. Some of the growth has been fueled by an infusion of federal monies related to …

-$450,000 Committed to Using Entrepreneurship as a Means of Economic Development- Richmond, VA – Activation Capital, a leading entrepreneurship and ecosystem development organization, was awarded $300,000 from GO Virginia for Region 4’s Regional Entrepreneurship Initiative (REI).  The funding, coupled with cash and in-kind donations from Altria, Dominion Energy, Greensville County and Activation Capital will total …

Roswell, GA and Greenville, SC – The Board of Directors of Southeast Life Sciences (SLS) has named Sam Konduros, Founder and President of Greenville-based SK Strategies, as Chief Executive Officer effective June 1, 2022. Mr. Konduros succeeds Jason Rupp in the leadership role, in which Mr. Rupp served from 2019 to 2022. Mr. Rupp’s tenure …

~ Virongy Biosciences Inc. to invest $471,000 to begin development of diagnostic technologies for viral pathogens ~ RICHMOND, VA – Governor Glenn Youngkin announced that Virongy Biosciences Inc., a developer of viral diagnostic technologies, anti-viral drugs, and therapeutic viral vectors, will invest $471,000 to expand in Prince William County. The company recently relocated to occupy over …

$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs Charlottesville, VA – UVA Health and the Charlottesville-based Focused Ultrasound Foundation today announced the launch of the Focused Ultrasound Cancer Immunotherapy Center, the world’s first center dedicated specifically to advancing a focused ultrasound and cancer immunotherapy treatment approach that could revolutionize 21st-century cancer …

Inhaled LPS Challenge Trial to Support Development of RLS-0071 in Severe Asthma RLS-0071 is ReAlta’s lead dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic ischemic encephalopathy, severe asthma, and other rare diseases Norfolk, VA, – ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing …

RICHMOND, VA – The Greater Richmond Partnership (GRP) was named among the top 20 economic development organizations in the nation according to Site Selection magazine, a national publication targeting site location professionals and corporate executives making relocation decisions. The 2022 Mac Conway Awards for Excellence in Economic Development, named in honor of Site Selection founding publisher …

TROY, Va.,/PRNewswire/ — A clinical trial designed by BIO-CAT, Inc – a biotech company specializing in enzyme development – studied the use of enzymes to improve digestion in an in vitro model of aging. The results showed that a multi-component supplemental enzyme blend (microbial proteases, lipase, amylase, and glucoamylase) effectively released nutrients from a balanced meal better …

CHARLOTTESVILLE, Va., – AMPEL BioSolutions announced a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat inflammatory skin diseases, such as Lupus, Psoriasis, Atopic Dermatitis and Scleroderma. Revealed in the peer-reviewed journal Science Advances, the paper details AMPEL’s breakthrough machine learning approach to characterize disease activity from gene expression data obtained …

Richmond medical technology company Tympanogen Inc. has raised $1 million in fresh funding, according to a Securities and Exchange Commission filing. Tympanogen raised the money from 12 investors and said it is seeking to raise up to $2.5 million through debt and other options, according to the March filing. The round includes participation from Williamsburg’s ShockVentures …

Caretaker Medical, a digital health leader in continuous “beat by beat” wireless patient monitoring technologies, announced that it has received FDA 510(k) Clearance for four new continuous hemodynamic parameters, adding cardiac output, stroke volume, heart rate variability, and left ventricular ejection time to its VitalStream™ non-invasive patient monitoring platform. This is the company’s 5th FDA …

Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, is pleased to announce its acquisition of Visionary Optics, a specialty scleral contact lens design and distribution pioneer. The acquisition signifies Euclid’s recognition of the value of joining forces with Visionary Optics, the only company in the US that concentrates almost …

Dr. Richard T. Marconi of VCU and Jeff Gallagher, former Virginia Bio CEO, are recognized for their outstanding contributions to the biosciences in the Commonwealth.   Richmond, VA, (April 22) – Every two years, the Virginia Biotechnology Association recognizes individual Virginians for their significant contributions to bioscience and the Virginia biotechnology ecosystem.  This year, Dr. …

Elkton, VA (EndpointNews) – A construction project built around expanding the vaccine manufacturing capabilities at a Merck site in Elkton, VA, has been completed. The upgrades will support the company’s human papillomavirus vaccine, Gardasil 9, once it gains review and approval from regulators. About 150 new jobs have been added to the site, as the …

Roanoke, VA (The Roanoke Times) – Virginia Western Community College announced this week it will be launching a new biotechnology degree program to keep pace with the region’s fast-growing industry. Students will earn a two-year associate degree in biotechnology that will prepare them to transfer to a four-year school for a bachelor’s degree or to …

RLS-0071 is ReAlta’s lead dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic-ischemic encephalopathy and other rare diseases Norfolk, VA, ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, today announced U.S. Food and …

ATCC’s collection of high-fidelity, authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research Manassas, VA, United States, ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide …

RICHMOND, VA  (Office of Governor Glenn Youngkin) – Governor Glenn Youngkin today announced that Embody, Inc., a Norfolk-based medical device company developing novel collagen-based technologies for soft tissue repair, will invest $5 million to expand its headquarters at Innovation Research Park at Old Dominion University in the City of Norfolk. The company will add 10,000 …